SG Americas Securities
MRVI icon

SG Americas Securities’s Maravai LifeSciences MRVI Stock Holding History

SG Americas Securities’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$71K Sell
24,996
-402,287
-94% -$1.36M ﹤0.01% 2988
2025
Q4 		$1.39M Sell
427,283
-72,952
-15% -$246K ﹤0.01% 1758
2025
Q3 		$1.44M Sell
500,235
-226,507
-31% -$578K ﹤0.01% 1166
2025
Q2 		$1.75M Buy
726,742
+30,835
+4% +$64.8K 0.01% 839
2025
Q1 		$1.54M Buy
695,907
+662,861
+2,006% +$2.62M 0.01% 899
2024
Q4 		$180K Buy
33,046
+2,239
+7% +$14.4K ﹤0.01% 2252
2024
Q3 		$256K Buy
+30,807
New +$266K ﹤0.01% 2283
2024
Q2 		– Sell
-52,753
Closed -$457K – 3136
2024
Q1 		$457K Sell
52,753
-41,003
-44% -$277K ﹤0.01% 1475
2023
Q4 		$614K Buy
+93,756
New +$606K 0.01% 1340
2022
Q4 		– Sell
-8,395
Closed -$214K – 3260
2022
Q3 		$214K Sell
8,395
-76,827
-90% -$1.93M ﹤0.01% 2274
2022
Q2 		$2.42M Buy
85,222
+82,360
+2,878% +$2.61M 0.03% 634
2022
Q1 		$101K Buy
2,862
+185
+7% +$6.2K ﹤0.01% 2769
2021
Q4 		$112K Buy
+2,677
New +$108K ﹤0.01% 3022
2021
Q3 		– Sell
-2,637
Closed -$110K – 3872
2021
Q2 		$110K Buy
+2,637
New +$102K ﹤0.01% 2618
2021
Q1 		– Sell
-24,000
Closed -$673K – 3454
2020
Q4 		$673K Buy
+24,000
New +$668K ﹤0.01% 1762

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SG Americas Securities's MRVI Position: Q1 2026 in Review

SG Americas Securities reduced its Maravai LifeSciences (MRVI) stake by 94% in Q1 2026, selling an estimated $1.36M and leaving 24,996 shares worth $71K. The position accounts for ﹤0.01% of the portfolio, ranked #2988.

SG Americas Securities first reported a position in MRVI in Q4 2020 and has held it in 15 quarters since. The position peaked at $2.42M in Q2 2022. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • SG Americas Securities held 24,996 shares of Maravai LifeSciences worth $71K as of Q1 2026.
  • SG Americas Securities sold 402,287 Maravai LifeSciences shares in Q1 2026, an estimated $1.36M.
  • Maravai LifeSciences made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2988 holding.
  • SG Americas Securities first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 15 quarters since.
  • SG Americas Securities's Maravai LifeSciences position peaked at $2.42M in Q2 2022.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.